Physician profile

Jordan Herbert

Psychiatric/Mental Health (Nurse Practitioner) · Southfield, MI

NPI 1073058475

$717.60

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$15.90

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $372.80 2021-2022
Lundbeck LLC $128.88 2021-2022
Takeda Pharmaceuticals U.S.A., INC. $90.17 2021-2022
Otsuka America Pharmaceutical, INC. $67.63 2021-2022
Abbvie INC. $24.16 2021
Avanir Pharmaceuticals, INC. $18.06 2022
Shockwave Medical, INC $15.90 2024 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jordan Herbert

$717.60

in general payments reported 2019-2025

Years
2021-2024
Top company
Iti, INC. (D/B/A Intra-Cellular Therapies, INC.)

https://glasscript.com/doctor/10860922/jordan-herbert

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.